KRISTIN JOINER: Open Payments
NPI 1073110649 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,345 in 70 payments from 14 companies in 2025. Trend: 2023 $1,072 · 2024 $1,400 · 2025 $1,345
Food & beverage: $1,345
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $614 |
| Madrigal Pharmaceuticals | 4 | $119 |
| Janssen Biotech, Inc. | 5 | $113 |
| Gilead Sciences, Inc. | 5 | $107 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $73 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $60 |
| Phathom Pharmaceuticals, Inc. | 4 | $45 |
| PFIZER INC. | 2 | $37 |
| QOL Medical, LLC | 2 | $37 |
| Regeneron Healthcare Solutions, Inc. | 2 | $35 |
Products named: RINVOQ, CREON, REZDIFFRA, TREMFYA, LINZESS, DUPIXENT, XIFAXAN, ENTYVIO.
Industry payments across IN — which companies pay providers there.
